Technical Analysis for ASNS - Arsanis, Inc.

Grade Last Price % Change Price Change
grade C 3.24 -1.82% -0.06
ASNS closed down 5.17 percent on Tuesday, January 15, 2019, on 7 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical ASNS trend table...

Date Alert Name Type % Chg
Jan 15 1,2,3 Pullback Bullish Bullish Swing Setup -1.82%
Jan 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.82%
Jan 15 Narrow Range Bar Range Contraction -1.82%
Jan 15 NR7 Range Contraction -1.82%
Jan 15 Inside Day Range Contraction -1.82%
Jan 15 Wide Bands Range Expansion -1.82%
Jan 15 Down 3 Days in a Row Weakness -1.82%
Jan 14 1,2,3 Pullback Bullish Bullish Swing Setup -6.90%
Jan 14 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.90%
Jan 14 Wide Bands Range Expansion -6.90%

Older signals for ASNS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Arsanis, Inc. is a United States-based company engaged in the discovery and development of monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company's mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and ASN500. Its lead program, ASN100, is being studied to prevent hospital-acquired Staphylococcus aureus pneumonia in mechanically ventilated patients heavily colonized with Staphylococcus aureus in their respiratory tracts. Its ASN200 addresses the unmet medical need caused by drug-resistant extra-intestinal escherichia coli infections. Its ASN300 addresses the unmet medical need due to carbapenem-resistant klebsiella pneumoniae infections. Its ASN400 addresses the unmet medical need due to streptococcus pneumoniae, a leading cause of mortality among the elderly. The ASN500 program consisting of potent mAbs targeting respiratory syncytial virus (RSV), is in the discovery phase.
Is ASNS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.69
52 Week Low 1.15
Average Volume 2,297,370
200-Day Moving Average 7.3999
50-Day Moving Average 2.6224
20-Day Moving Average 3.07
10-Day Moving Average 3.352
Average True Range 0.4779
ADX 44.23
+DI 32.6153
-DI 12.0383
Chandelier Exit (Long, 3 ATRs ) 3.3563
Chandelier Exit (Short, 3 ATRs ) 3.6737
Upper Bollinger Band 3.9988
Lower Bollinger Band 2.1412
Percent B (%b) 0.62
BandWidth 60.508143
MACD Line 0.1942
MACD Signal Line 0.1745
MACD Histogram 0.0197
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.63
Resistance 3 (R3) 3.65 3.57 3.58
Resistance 2 (R2) 3.57 3.48 3.56 3.56
Resistance 1 (R1) 3.43 3.43 3.39 3.41 3.54
Pivot Point 3.35 3.35 3.33 3.34 3.35
Support 1 (S1) 3.21 3.26 3.17 3.19 3.06
Support 2 (S2) 3.13 3.21 3.12 3.04
Support 3 (S3) 2.99 3.13 3.03
Support 4 (S4) 2.97